ELMO1 and arthritic joint disease: As expected, both Elmo1+/+ and Elmo1–/– mice injected with K/BxN serum developed severe arthritis compared to the PBS-injected controls, manifesting the onset of clinical signs (Figure 4A) and increase of ankle thickness (Figure 4B) within 6 days.